Researchers at the University of Washington found that while budtenders were good about educating their customers over the benefits of weed, they didn’t warn them about all the evils that could arise.

Step inside any marijuana dispensary across the United States, and you’ll be greeted by a crew of dedicated budtenders whose job is to sell you weed. The transaction might be similar to other retail experiences you’ve had over the years. They’ll see if they can help you find anything specific. If you’re not sure what you want, the budtender might even ask you some questions and then make some recommendations based on your response.

A new study is going straight to healthcare workers in the U.S. and Canada to get their input on their experiences with and advice about medical cannabis.

The exploration is part of a recently announced study that will involve the Cannabis Center of Excellence, Inc. (CCOE), Medicinal Genomics and the University of Massachusetts’ Dartmouth Charlton College of Business, Cannabis Science and Technology reports.

A recently released Canadian study has found that authorizations to use medical cannabis for chronic pain patients correlated to a reduction in opioid use among those to whom they are prescribed. A report on the research, “Opioid use in medical cannabis authorization for adult patients from 2013 to 2018: Alberta, Canada,” was published earlier this month in the journal BMC Public Health.

If there is one substance you hear about a lot right now it is cannabis. Some people are against the use of this ‘drug’ while others swear their life has been improved by using by-products of the cannabis sativa plant. So, are there studies and science to back up the claims that cannabis offers health benefits? Indeed, there is evidence that this natural plant and the cannabinoids it contains may offer health benefits. So, let’s take a closer look.

A recently released Canadian study has found that authorizations to use medical cannabis for chronic pain patients correlated to a reduction in opioid use among those to whom they are prescribed. A report on the research, “Opioid use in medical cannabis authorization for adult patients from 2013 to 2018: Alberta, Canada,” was published earlier this month in the journal BMC Public Health.

Study after study is finding that not only does CBD oil help with headaches, but also pain related to inflammation and anxiety.

It’s often said that there is nothing like the exhaustion of a thyroid condition. The endocrine system, when not in working order, can wreak havoc on many functions within the body. Functions like:

Tremors are uncontrollable, unintentional movements that affect a limb or a part of it. It’s one of the most common movement disorders and it can happen anywhere in the body. They usually affect the arms, vocal cords, head, legs, and torso.

Vancouver-based companies Optimi Health and Numinus Wellness are one step closer to conducting clinical trials for psilocybin after submitting an information package to Health Canada.

With the assistance of the Impact Clinical Trials Accelerator at the University of Calgary, the companies announced they had submitted the application for review and comment. If approved, Numinus plans to develop an all-natural psilocybin capsule for use in Optimi’s human clinical trials.

Simply explained, cannabinoid acids are precursors to the cannabinoids we all know and love, like THC and CBD. They are found on the stems, leaves and flowers of certain strains of raw cannabis before any type of heat application or processing takes place.